ASTROCYTOMA, GRADE III
Clinical trials for ASTROCYTOMA, GRADE III explained in plain language.
Never miss a new study
Get alerted when new ASTROCYTOMA, GRADE III trials appear
Sign up with your email to follow new studies for ASTROCYTOMA, GRADE III, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Gene therapy fights deadliest brain tumors
Disease control Recruiting nowThis study tests a new gene therapy (HSV-tk) plus valacyclovir, along with radiation and chemotherapy, in people with recurrent glioblastoma, an aggressive brain cancer. The goal is to see if this combination can help patients live longer. About 62 adults whose cancer has returne…
Matched conditions: ASTROCYTOMA, GRADE III
Phase: PHASE1, PHASE2 • Sponsor: David Baskin MD • Aim: Disease control
Last updated May 17, 2026 00:49 UTC
-
New hope for glioblastoma: experimental combo enters human trials
Disease control Recruiting nowThis study tests a new drug (Debio 0123) combined with standard chemotherapy (temozolomide) and radiation in adults with glioblastoma, an aggressive brain cancer. The first phase finds the safest dose; the second phase checks if the combination helps people live longer. About 116…
Matched conditions: ASTROCYTOMA, GRADE III
Phase: PHASE1, PHASE2 • Sponsor: Debiopharm International SA • Aim: Disease control
Last updated May 17, 2026 00:49 UTC